back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-02-01 15:12 Tx date 2021-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$125,850
+15,000 vol $8.39 each |
95,000 | |
| Filed 2021-02-01 15:12 Tx date 2021-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$241,199
+30,000 vol $8.04 each |
80,000 | |
| Filed 2021-02-01 15:11 Tx date 2021-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$346,000
+50,000 vol $6.92 each |
50,000 | |
| Filed 2021-02-01 15:10 Tx date 2018-02-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-01 15:10 Tx date 2021-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-125,850
-15,000 vol $8.39 each |
30,000 | |
| Filed 2021-02-01 15:09 Tx date 2021-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-241,200
-30,000 vol $8.04 each |
45,000 | |
| Filed 2021-02-01 15:08 Tx date 2021-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-346,000
-50,000 vol $6.92 each |
75,000 | |
| Filed 2020-06-16 11:50 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$472,500
+30,000 vol $15.75 each |
125,000 | |
| Filed 2020-06-03 20:24 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
||
| Filed 2020-06-03 20:24 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
125,000 | |
| Filed 2019-07-05 12:26 Tx date 2019-07-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$125,850
+15,000 vol $8.39 each |
95,000 | |
| Filed 2019-02-01 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$241,199
+30,000 vol $8.04 each |
80,000 | |
| Filed 2018-03-02 Tx date 2018-02-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-02 Tx date 2018-02-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$346,000
+50,000 vol $6.92 each |
50,000 |